Parvez Mulani

5.8k citations

157 papers · 4.5k indexed · 1 hit paper · h-index 36

Impact in

Dermatology top 0.5%
- Hidradenitis Suppurativa and Treatments
- Dermatology and Skin Diseases
Genetics top 0.5%
- Inflammatory Bowel Disease

Papers in

Genetics 107
- Inflammatory Bowel Disease 107
Epidemiology 86
- Microscopic Colitis 85

Co-authors: Andrew P. Yu Eric Q. Wu Jingdong Chao Yanjun Bao Shiraz R. Gupta James Signorovitch William J. Sandborn Alexa B. Kimball
Journals: Gastroenterology (29 papers)The American Journal of Gastroenterology (29 papers)Inflammatory Bowel Diseases (17 papers)Journal of Crohn s and Colitis (12 papers)Value in Health (7 papers)
Partner nations: United States Germany Canada

In The Last Decade

Parvez Mulani

149 papers receiving 4.4k citations

Hit Papers

align trajectories log scale

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa 2012 · 305 citations

Peers

Countries citing papers authored by Parvez Mulani

Since Specialization

Citations

This map shows the geographic impact of Parvez Mulani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvez Mulani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvez Mulani more than expected).

Fields of papers citing papers by Parvez Mulani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvez Mulani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvez Mulani. The network helps show where Parvez Mulani may publish in the future.

Co-authors

The 25 scholars most cited alongside Parvez Mulani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Parvez Mulani Line = papers co-authored together Parvez Mulani links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names Advances in Therapy ·Jingdong Chao, Martha Skup, Wang Ming-x, Namita Tundia, Dendy Macaulay, Eric Q. Wu, Parvez Mulani	2015	8
2	Direct and Indirect Resource Use and Costs Associated With Non-Infectious Non-Anterior Uveitis Investigative Ophthalmology & Visual Science ·Jennifer E. Thorne, Namita Tundia, Martha Skup, Dendy Macaulay, M Li, Jingdong Chao, Parvez Mulani, Andrew D. Dick	2014	1
3	Risk of Leaving the Workforce in Non-infectious Uveitis Investigative Ophthalmology & Visual Science ·Namita Tundia, Martha Skup, Rachael Sorg, Dendy Macaulay, Jingdong Chao, Parvez Mulani, Jennifer E. Thorne	2014	1
4	PWE-254 Impact of induction dosing on maintenance outcome with adalimumab in Crohn's disease Gut ·J F Colombel, P. J. Rutgeerts, William J. Sandborn, Walter Reinisch, Edward V. Loftus, Jackson Tang, P Pollack, Mei Yang, Saagar Patel, B Huang, J. Chao, Parvez Mulani	2012	3
5	PWE-253 Adalimumab improves health-related quality of life for 52 weeks in patients with ulcerative colitis: Abstract PWE-253 Table 1 Gut ·William J. Sandborn, Gert Van Assche, Roopal Thakkar, A. Lazar, Martina Kron, Mei Yang, Saagar Patel, J. Chao, Parvez Mulani	2012	2
6	Risks of developing psychiatric disorders in pediatric patients with psoriasis Journal of the American Academy of Dermatology ·Alexa B. Kimball, Eric Q. Wu, Annie Guérin, Andrew P. Yu, Magda Tsaneva, Shiraz R. Gupta, Yanjun Bao, Parvez Mulani	2012	147
7	Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa Annals of Internal Medicine ·Alexa B. Kimball, Francisco A. Kerdel, David R. Adams, Ulrich Mrowietz, Joel M. Gelfand, Robert Gniadecki, Errol P. Prens, Joel Schlessinger, Christos C. Zouboulis, Hessel H. van der Zee, Belal Zaqaibeh, Parvez Mulani, Yihua Gu, Susan K. Paulson, Martin M. Okun, Gregor B. E. Jemec	2012	7
8	Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend: Table 1 Gut ·W. Sandborn, J F Colombel, Kathleen G. Lomax, P Pollack, Roopal Thakkar, A. Camez, Lijuan Hua, Mei Yang, J. Chao, Parvez Mulani	2011	10
9	Markov model projection of remission status for early versus delayed step-up adalimumab use in moderate to severe crohn's disease Gut ·Edward V. Loftus, J. Chao, Mei Yang, P Pollack, G. Groppo, Roopal Thakkar, Parvez Mulani	2011	1
10	Adalimumab real-world dosage pattern and predictors of weekly dosing: Patients with Crohn's disease in the United States Journal of Crohn s and Colitis ·Edward V. Loftus, Xiaoyun Pan, Issoufou Sandao, Parvez Mulani, Jingdong Chao	2011	10
11	The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis Journal of the American Academy of Dermatology ·Alexa B. Kimball, Andrew P. Yu, James Signorovitch, Jipan Xie, Magda Tsaneva, Shiraz R. Gupta, Yanjun Bao, Parvez Mulani	2011	58
12	Coronary Heart Disease and Stroke Risk in Patients with Psoriasis: Retrospective Analysis The American Journal of Medicine ·Alexa B. Kimball, Annie Guérin, Dominick Latrémouille-Viau, Andrew P. Yu, Shiraz R. Gupta, Yanjun Bao, Parvez Mulani	2010	90
13	Risk–benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohnʼs disease Inflammatory Bowel Diseases ·Edward V. Loftus, Scott J. Johnson, Fernando Sánchez Costa, Eric Q. Wu, Parvez Mulani, Jingdong Chao	2010	9
14	Systematic review: the costs of ulcerative colitis in Western countries Alimentary Pharmacology & Therapeutics ·Russell D. Cohen, Andrew P. Yu, Eric Q. Wu, Jiuyong Xie, Parvez Mulani, J. Chao	2010	226
15	The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial Journal of the American Academy of Dermatology ·Alan Menter, Matthias Augustin, James Signorovitch, Andrew P. Yu, Eric Q. Wu, Shiraz R. Gupta, Yanjun Bao, Parvez Mulani	2010	156
16	Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study Gastroenterology ·Brian G. Feagan, Remo Panaccione, William J. Sandborn, Geert D’Haens, Stefan Schreiber, Paul Rutgeerts, Edward V. Loftus, Kathleen G. Lomax, Andrew P. Yu, Eric Q. Wu, Jingdong Chao, Parvez Mulani	2008	294
17	Mapping FACT-P and EORTC QLQ-C30 to Patient Health Status Measured by EQ-5D in Metastatic Hormone-Refractory Prostate Cancer Patients Value in Health ·Eric Q. Wu, Parvez Mulani, Max H. Farrell, Darryl J. Sleep	2007	71
18	Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer Quality of Life Research ·Patrick W. Sullivan, Parvez Mulani, Mayer Fishman, Darryl J. Sleep	2007	62
19	Role of Quality of Life in Men with Metastatic Hormone-Refractory Prostate Cancer: How Does Atrasentan Influence Quality of Life? European Urology ·David Cella, Daniel P. Petrylak, Mayer Fishman, Chris M. Teigland, Jay M. Young, Parvez Mulani	2006	21
20	Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer Quality of Life Research ·Patrick W. Sullivan, Joel B. Nelson, Parvez Mulani, Darryl J. Sleep	2006	60

About Parvez Mulani

Parvez Mulani is a scholar working on Genetics, Epidemiology, Speech and Hearing, Dermatology and Immunology, having authored 157 papers that have together received 4.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (107 papers), Microscopic Colitis (85 papers), Eosinophilic Esophagitis (28 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers), Psoriasis: Treatment and Pathogenesis (16 papers), Adolescent and Pediatric Healthcare (11 papers), Prostate Cancer Treatment and Research (10 papers) and Pharmaceutical studies and practices (9 papers). The work is most often cited by research in Dermatology (905 citations), Genetics (2.0k citations), Biological Psychiatry (144 citations), Epidemiology (1.9k citations) and Immunology (1.1k citations). Parvez Mulani has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Andrew P. Yu, Eric Q. Wu, Jingdong Chao, Yanjun Bao, Shiraz R. Gupta, James Signorovitch, William J. Sandborn, Alexa B. Kimball, Edward V. Loftus and Annie Guérin. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Inflammatory Bowel Diseases, Journal of Crohn s and Colitis and Value in Health.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact